Free VTE Risk Score Calculator for Pregnancy
Select patient type and add risk factors to calculate the VTE risk score
Choose all relevant risk factors from the categories below
Pregnancy and the postpartum period are well‑established windows of increased vulnerability to venous thromboembolism (VTE). For clinicians who need to quantify this risk efficiently, the VTE Risk Score Calculator — Pregnancy & Postpartum Risk Assessment Online provides a structured framework built on the Royal College of Obstetricians and Gynaecologists (RCOG) guidelines. By systematically scoring pre‑existing, obstetric, and transient risk factors, the tool returns a total point value that helps inform decisions about mechanical or pharmacological thromboprophylaxis.
Understanding Venous Thromboembolism
VTE is an umbrella term that includes deep vein thrombosis (DVT) and pulmonary embolism (PE). The underlying pathophysiology is described by Virchow’s triad: venous stasis, endothelial injury, and hypercoagulability. During pregnancy several physiological changes converge to create a prothrombotic milieu:
- The growing uterus compresses the pelvic veins.
- The right iliac artery compresses the left iliac vein.
- Hormonal shifts alter pro‑coagulant, anticoagulant, and fibrinolytic pathways, shifting the balance toward clot formation.
As a result, VTE occurs four to ten times more frequently in pregnant women than in non‑pregnant peers of the same age. Recognizing this elevated risk, the RCOG has issued detailed guidance for systematic risk assessment and prophylaxis.
RCOG Risk Factor Categories
The RCOG scheme divides risk factors into three groups, each carrying predefined point values. The calculator sums these points to produce a total score that reflects the patient’s overall VTE risk.
Pre‑existing Risk Factors
| Risk Factor | Points |
|---|---|
| Body mass index (BMI) 30–39 | 1 |
| BMI ≥ 40 | 2 |
| Maternal age > 35 years | 1 |
| Known high‑risk thrombophilia (e.g., antithrombin deficiency, protein C or S deficiency, homozygous or compound low‑risk mutations) | 3 |
| Medical comorbidities – cancer, heart failure, active SLE, inflammatory bowel disease, nephrotic syndrome, type 1 diabetes with nephropathy, sickle cell disease, current IV drug use | 3 |
| Family history of unprovoked or estrogen‑related VTE in a first‑degree relative | 1 |
| Low‑risk thrombophilia (heterozygous factor V Leiden or prothrombin G20210A) without personal VTE | 1 |
| Parity ≥ 3 (pregnancies reaching 24 weeks) | 1 |
| Current smoker | 1 |
| Gross varicose veins | 1 |
Obstetric Risk Factors
| Risk Factor | Points |
|---|---|
| Pre‑eclampsia in the current pregnancy | 1 |
| ART/IVF (assisted reproductive technology / in‑vitro fertilization) – antenatal assessment only | 1 |
| Multiple pregnancy (twins, triplets, etc.) | 1 |
| Cesarean section performed in labor | 2 |
| Elective cesarean section | 1 |
| Mid‑cavity or rotational operative vaginal delivery | 1 |
| Prolonged labor (> 24 hours) | 1 |
| Postpartum hemorrhage (> 1 L or requiring transfusion) | 1 |
| Preterm birth (< 37+0 weeks) | 1 |
| Stillbirth in the current pregnancy | 1 |
Transient Risk Factors
| Risk Factor | Points |
|---|---|
| Any surgical procedure in pregnancy or puerperium (excluding immediate perineal repair) | 3 |
| Hyperemesis gravidarum | 3 |
| Ovarian hyperstimulation syndrome (OHSS) – first trimester only | 4 |
| Current systemic infection | 1 |
| Immobility or dehydration | 1 |
How to Use the VTE Risk Score Calculator
Obtaining a risk score is a straightforward process:
- Identify the clinical period – choose whether the patient is currently pregnant or in the postpartum phase.
- Provide BMI – enter the BMI directly, or input height and weight for automatic calculation.
- Indicate age – confirm whether the patient is older than 35 years.
- Select risk factors – tick the checkboxes corresponding to any applicable factors from the three categories.
The calculator instantly sums the points and displays the total VTE risk score. This numeric result, together with clinical examination and overall patient assessment, helps clinicians decide whether prophylaxis is warranted and which type is most appropriate.
VTE Prophylaxis in Pregnancy and Postpartum
Prophylaxis can be mechanical, pharmacological, or a combination of both.
Mechanical methods include:
- Graduated compression stockings
- Intermittent pneumatic compression devices
- Calf‑pumping exercises
- Early ambulation after delivery or surgery
Pharmacological options (typically reserved for women with an intermediate or high score):
- Low‑molecular‑weight heparin (LMWH) – the agent of choice for antenatal and postnatal prophylaxis; safe for breastfeeding.
- Unfractionated heparin (UFH) – used only in very‑high‑risk situations or when LMWH is contraindicated.
- Vitamin K antagonists (e.g., warfarin) – generally avoided during pregnancy except in specific scenarios (e.g., mechanical heart valves); safe during breastfeeding.
- Direct oral anticoagulants (DOACs) – employed only after consultation with a hematologist.
- Aspirin – not recommended for VTE prophylaxis in pregnancy or the puerperium.
It is important to note that pharmacological prophylaxis does not preclude the simultaneous use of mechanical measures; in many cases, both strategies are applied together to achieve optimal risk reduction.
Important: This tool is designed to support clinical decision‑making and should not replace individualized medical evaluation. All treatment decisions must be made in consultation with a qualified healthcare provider.
FAQ
1. What is VTE and why is it more common during pregnancy?
VTE stands for venous thromboembolism, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Pregnancy increases risk due to venous stasis from uterine compression, compression of the left iliac artery, and hormonal changes that create a prothrombotic state. As a result, VTE is four to ten times more likely in pregnant women than in non‑pregnant peers.
2. Which RCOG risk factor categories are used in the calculator?
The calculator uses three categories: pre‑existing risk factors (e.g., obesity, age, thrombophilia), obstetric risk factors (e.g., pre‑eclampsia, multiple pregnancy, cesarean section), and transient risk factors (e.g., surgery, hyperemesis, infection). Each factor is assigned a point value that contributes to the total VTE risk score.
3. How do I use the VTE Risk Score Calculator?
First, indicate whether the patient is pregnant or postpartum. Then enter the patient's BMI (or height and weight). Confirm if she is over 35. Finally, tick all applicable risk factors from the provided lists. The calculator sums the points and displays the total score.
4. What is the recommended pharmacological prophylaxis for VTE in pregnancy?
Low‑molecular‑weight heparin (LMWH) is the first‑line choice for antenatal and postnatal prophylaxis and is safe for breastfeeding. Unfractionated heparin is used only in very‑high‑risk situations. Vitamin K antagonists like warfarin are generally avoided during pregnancy except in special cases, and DOACs are used only after hematology consultation.
5. Can mechanical and pharmacological prophylaxis be used together?
Yes, mechanical methods such as compression stockings, intermittent pneumatic compression, and early ambulation can be used alongside pharmacological prophylaxis. In fact, they are often combined to achieve better risk reduction.
How to Use
- Select whether the patient is currently pregnant or postpartum (within 6 weeks after delivery), then enter height and weight to auto-calculate BMI.
- Tick all applicable risk factors from the pre-existing, obstetric, and transient categories based on the RCOG guidelines.
- Review the total VTE risk score, risk level, and prophylaxis recommendation. Use the score breakdown to see which factors contributed.